We are live on ! Find out more
VIRS

Pacer BioThreat Strategy ETF
VIRS

Delisted

VIRS was delisted on the 10th of October, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Pacer BioThreat Strategy ETF in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $1.34M → $0 (-$1.34M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$838K
2
Osaic Holdings
Osaic Holdings
Arizona
-$359K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$109K
4
UBS Group
UBS Group
Switzerland
-$38.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
– -$838K -21,048 Closed
Osaic Holdings
2
Osaic Holdings
Arizona
– -$359K -9,007 Closed
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
– -$109K -2,729 Closed
UBS Group
4
UBS Group
Switzerland
– -$38.8K -974 Closed

VIRS Hedge Fund Activity: Q4 2024 in Review

0 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q4 2024, worth a combined $0 — down 100% from $1.34M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of VIRS and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $838K sold.

  • 0 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q4 2024, down from 4 in Q3 2024.
  • Funds reported $0 of Pacer BioThreat Strategy ETF stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Pacer BioThreat Strategy ETF positions in Q4 2024 and 4 closed out, a net change of -4 holders.
  • The largest Pacer BioThreat Strategy ETF seller in Q4 2024 was Susquehanna International Group, an estimated $838K sold.

Based on aggregated 13F filings for Q4 2024.